Pesticidal compositions and processes related thereto
US-2017158598-A1 · Jun 8, 2017 · US
Compounds for the treatment of proliferative disorders
US9102601B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9102601-B2 |
| Application number | US-201414336852-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jul 21, 2014 |
| Priority date | Aug 21, 2006 |
| Publication date | Aug 11, 2015 |
| Grant date | Aug 11, 2015 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
Disclosed are compounds and pharmaceutical compositions that are useful for treating a subject with a proliferative disorder, such as cancer. The disclosed compounds and pharmaceutical compositions are also useful for treating disorders responsive to Hsp70 induction and/or natural killer induction.
First claim
Opening claim text (preview).
What is claimed is: 1. A method of treating an Hsp70 responsive disorder, comprising administering to a subject in need thereof an effective amount of a compound represented by the following structural formula: or a tautomer, or pharmaceutically acceptable salt thereof, wherein: Q is —(CR 14 R 15 ) r —, an optionally substituted (C 6 )aryl group or an optionally substitu…
Assignees
Inventors
Classifications
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9102601B2 cover?
- Disclosed are compounds and pharmaceutical compositions that are useful for treating a subject with a proliferative disorder, such as cancer. The disclosed compounds and pharmaceutical compositions are also useful for treating disorders responsive to Hsp70 induction and/or natural killer induction.
- Who is the assignee on this patent?
- Synta Pharmaceuticals Corp
- What technology area does this patent fall under?
- Primary CPC classification C07C327/56. Mapped technology areas include Chemistry & Metallurgy.
- When was this patent published?
- Publication date Tue Aug 11 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).